BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36253324)

  • 1. A Redox-Controlled Substrate Engineering Strategy for Site-Specific Enzymatic Fucosylation.
    Lu N; Li Y; Xia H; Zhong K; Jia C; Ye J; Liu X; Liu CC; Cao H
    Angew Chem Int Ed Engl; 2022 Dec; 61(50):e202211032. PubMed ID: 36253324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro alpha1-3 or alpha1-4 fucosylation of type I and II oligosaccharides with secreted forms of recombinant human fucosyltransferases III and VI.
    Nimtz M; Grabenhorst E; Gambert U; Costa J; Wray V; Morr M; Thiem J; Conradt HS
    Glycoconj J; 1998 Sep; 15(9):873-83. PubMed ID: 10052591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Biomimetic Synthetic Strategy Can Provide Keratan Sulfate I and II Oligosaccharides with Diverse Fucosylation and Sulfation Patterns.
    Wu Y; Bosman GP; Chapla D; Huang C; Moremen KW; de Vries RP; Boons GJ
    J Am Chem Soc; 2024 Apr; 146(13):9230-9240. PubMed ID: 38494637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of
    Yang Q; Zhang R; Cai H; Wang LX
    J Biol Chem; 2017 Sep; 292(36):14796-14803. PubMed ID: 28729420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Combination of Structural, Genetic, Phenotypic and Enzymatic Analyses Reveals the Importance of a Predicted Fucosyltransferase to Protein
    Tomek MB; Janesch B; Braun ML; Taschner M; Figl R; Grünwald-Gruber C; Coyne MJ; Blaukopf M; Altmann F; Kosma P; Kählig H; Comstock LE; Schäffer C
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucosyltransferase substrate specificity and the order of fucosylation in invertebrates.
    Paschinger K; Staudacher E; Stemmer U; Fabini G; Wilson IB
    Glycobiology; 2005 May; 15(5):463-74. PubMed ID: 15604090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescently labeled substrates for monitoring α1,3-fucosyltransferase IX activity.
    Lunau N; Seelhorst K; Kahl S; Tscherch K; Stacke C; Rohn S; Thiem J; Hahn U; Meier C
    Chemistry; 2013 Dec; 19(51):17379-90. PubMed ID: 24258785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
    Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
    Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific fucosylation of sialylated polylactosamines by alpha1,3/4-fucosyltransferases-V and -VI Is defined by amino acids near the N terminus of the catalytic domain.
    Shetterly S; Jost F; Watson SR; Knegtel R; Macher BA; Holmes EH
    J Biol Chem; 2007 Aug; 282(34):24882-92. PubMed ID: 17604274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic midchain branching of polylactosamine backbones is restricted in a site-specific manner in alpha 1,3-fucosylated chains.
    Leppänen A; Niemelä R; Renkonen O
    Biochemistry; 1997 Nov; 36(44):13729-35. PubMed ID: 9354644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting substrate glycans of fucosyltransferases with fluorophore-conjugated fucose and methods for glycan electrophoresis.
    Wu ZL; Whittaker M; Ertelt JM; Person AD; Kalabokis V
    Glycobiology; 2020 Dec; 30(12):970-980. PubMed ID: 32248235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H. pylori α1-3/4-fucosyltransferase (Hp3/4FT)-catalyzed one-pot multienzyme (OPME) synthesis of Lewis antigens and human milk fucosides.
    Yu H; Li Y; Wu Z; Li L; Zeng J; Zhao C; Wu Y; Tasnima N; Wang J; Liu H; Gadi MR; Guan W; Wang PG; Chen X
    Chem Commun (Camb); 2017 Oct; 53(80):11012-11015. PubMed ID: 28936496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lung adenocarcinoma alpha1,3/4-L-fucosyltransferase displays two molecular forms, high substrate affinity for clustered sialyl LacNAc type 1 units as well as mucin core 2 sialyl LacNAc type 2 unit and novel alpha1,2-L-fucosylating activity.
    Chandrasekaran EV; Chawda R; Rhodes JM; Xia J; Piskorz C; Matta KL
    Glycobiology; 2001 May; 11(5):353-63. PubMed ID: 11425796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha 1-->3 fucosylation at the penultimate GlcNAc catalyzed by fucosyltransferase VII is blocked by internally fucosylated residue in sialosyl long-chain poly-LacNAc: enzymatic basis for expression of physiological E-selectin epitope.
    Handa K; Withers DA; Hakomori S
    Biochem Biophys Res Commun; 1998 Feb; 243(1):199-204. PubMed ID: 9473504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for substrate specificity and catalysis of α1,6-fucosyltransferase.
    García-García A; Ceballos-Laita L; Serna S; Artschwager R; Reichardt NC; Corzana F; Hurtado-Guerrero R
    Nat Commun; 2020 Feb; 11(1):973. PubMed ID: 32080177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Helicobacter pylori alpha1,2-fucosyltransferase, a key enzyme in the synthesis of Lewis antigens.
    Wang G; Boulton PG; Chan NWC; Palcic MM; Taylor DE
    Microbiology (Reading); 1999 Nov; 145 ( Pt 11)():3245-3253. PubMed ID: 10589734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucosyltransferases produce N-glycans containing core l-galactose.
    Ohashi H; Ohashi T; Kajiura H; Misaki R; Kitamura S; Fujiyama K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):658-663. PubMed ID: 27993676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemo-enzymatic modification of poly-N-acetyllactosamine (LacNAc) oligomers and N,N-diacetyllactosamine (LacDiNAc) based on galactose oxidase treatment.
    Kupper CE; Rosencrantz RR; Henßen B; Pelantová H; Thönes S; Drozdová A; Křen V; Elling L
    Beilstein J Org Chem; 2012; 8():712-25. PubMed ID: 23015818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant decrease in alpha1,3-linked fucose in association with increase in 6-sulfated N-acetylglucosamine in peripheral lymph node addressin of FucT-VII-deficient mice exhibiting diminished lymphocyte homing.
    Hiraoka N; Petryniak B; Kawashima H; Mitoma J; Akama TO; Fukuda MN; Lowe JB; Fukuda M
    Glycobiology; 2007 Mar; 17(3):277-93. PubMed ID: 17172261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human alpha1,3/4-fucosyltransferases. III. A Lys/Arg residue located within the alpha1,3-FucT motif is required for activity but not substrate binding.
    Sherwood AL; Nguyen AT; Whitaker JM; Macher BA; Stroud MR; Holmes EH
    J Biol Chem; 1998 Sep; 273(39):25256-60. PubMed ID: 9737990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.